Looking at GLP-1 programs? Discover the key differences between Eden and Noom’s approach to GLP-1 access, physician support, and ongoing care.
GLP-1 medications have become a rising topic in health and wellness conversations. As more people explore medical options for improving metabolic health, platforms like Eden and Noom are offering pathways to connect patients with these treatments.
While both Eden and Noom promote GLP-1 program access, the experience, physician involvement, cost transparency, and level of care provided are significantly different.
If you are evaluating your options and want to make an informed decision, this guide breaks down how Eden and Noom compare across the areas that matter most.
Eden is a digital health platform that focuses on connecting patients with independent licensed physicians to evaluate potential treatment for metabolic health using GLP-1 medications. Eden does not manufacture medications or function as a pharmacy. Instead, it offers a clinical pathway where real physicians evaluate your eligibility and coordinate prescriptions through state-licensed pharmacies if treatment is deemed appropriate.
Eden provides:
Everything starts with a medical conversation. There is no obligation, and your treatment is guided by a licensed physician who understands your goals and medical history.
Ready to take the first step? Get started with Eden now.
Noom began as a lifestyle app designed to help people lose weight through behavioral change and coaching. In recent years, it introduced a GLP-1 program through Noom Med, a separate track that provides limited medical access and medication recommendations.
Here is what Noom includes:
Noom’s model can be appealing to people who want a coach-led structure, but it may not offer the same direct medical supervision or medication access process that Eden does.
{{primary-cta}}
With Eden, every step begins with a consultation from a licensed physician. This doctor reviews your health history, evaluates your goals, and discusses whether treatment is appropriate. If the physician determines that a GLP-1 medication fits your needs, a prescription is coordinated through a state-licensed pharmacy.
This approach gives patients confidence knowing their care is guided by medical professionals who provide personalized assessments, not one-size-fits-all solutions.
Noom centers around behavior change. While there is medical input within the Noom Med program, much of the user experience relies on app-based coaching and personal habit tracking. Although coaching can be helpful for building habits, individuals who value clinical oversight may find Eden’s doctor-led model more aligned with their goals.
Eden provides a straightforward, transparent fee structure. One flat rate includes:
This clear, bundled pricing means there are no surprises or hidden fees. You will know exactly what to expect before starting.
Want clarity before you commit? Explore Eden’s pricing and next steps here.
Noom may appear lower in cost at first glance. However, medication is typically not included in the base subscription, and users may need to work with outside pharmacies or insurance providers. This can add complexity and potentially increase costs over time.
Eden connects patients with physicians who may prescribe GLP-1 medications when clinically appropriate. These prescriptions are filled by state-licensed pharmacies and delivered directly to the patient.
This end-to-end coordination saves time and avoids pharmacy visits or insurance confusion.
With Noom, access to medication often depends on insurance coverage, location, and pharmacy partnerships. Users may need to manage prescriptions independently or encounter delays due to pharmacy backlogs.
Eden’s model provides patients with continued access to the physician they consulted with, supporting ongoing care and monitoring. This relationship allows for treatment adjustments when appropriate and helps ensure that care remains aligned with the patient’s health goals and evolving needs.
Noom’s ongoing support is based on digital health coaching and tracking tools. While useful for habit formation, this model may not offer the same peace of mind as consistent clinical oversight.
Prefer to have a doctor manage your care from start to finish? Begin with Eden now.
GLP-1 receptor agonists have been studied for their role in improving metabolic function. These medications were originally developed to help manage type 2 diabetes, but recent research has shown benefits in other areas of health.
These results underscore why more people are exploring GLP-1 therapy as part of a broader plan for better health.
*In the STEP 1 2021 study, the type of semaglutide used was injectable semaglutide 2.4 mg, administered once weekly. This formulation is the same as what was later approved and marketed under the brand name Wegovy® specifically for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
**In the SURMOUNT-1 trial, the GLP-1/GIP receptor agonist tirzepatide was used in once-weekly subcutaneous injections at doses of 5 mg, 10 mg, and 15 mg to evaluate its effectiveness in weight management among adults with obesity or overweight without diabetes. This is the same active ingredient later approved and marketed as Zepbound® for chronic weight management.
{{primary-cta}}
Choosing between Eden and Noom for a GLP-1 program comes down to your priorities.
If you value clear pricing, consistent medical supervision, and personalized support from licensed doctors, Eden offers a focused and clinically guided experience. If you are looking for behavioral coaching with occasional medical access, Noom may be worth exploring.
For those who want clarity, care, and access in one place, Eden makes getting started simple.
Find out if Eden’s physician-led GLP-1 program is right for you. Begin your consultation here.
Eden is not a pharmacy and does not manufacture or dispense medication. Eden connects patients to licensed physicians who determine eligibility for treatment. If treatment is prescribed, medications are fulfilled by licensed pharmacies. Eden does not provide medical care directly and does not promote medications for uses that are not reviewed and approved by your consulting physician. Always consult with a qualified healthcare provider before starting any new treatment.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
